血根堿
| 中文名稱 | 血根堿 |
|---|---|
| 中文同義詞 | 血根堿;血根堿(標(biāo)準(zhǔn)品);血根鹼;SANGUINARINE 血根堿;血根堿.博落回提取物;假白屈菜季銨堿;血根堿40%;血根堿(假白屈菜季銨堿) |
| 英文名稱 | SANGUINARINE |
| 英文同義詞 | SANGUINARINE, 98+% BY HPLC;SANGUINARINE, 40+% BY UV;Sangrovit;Sanguinarine/Macleaya cordata extract;13-Methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium;C06162;PSEUDOCHELERYTHRINE;SANGUINARIN |
| CAS號 | 2447-54-3 |
| 分子式 | C20H14NO4 |
| 分子量 | 332.33 |
| EINECS號 | 219-503-3 |
| 相關(guān)類別 | 中藥對照品;小分子抑制劑;對照品;小分子抑制劑,天然產(chǎn)物;植物提取物;標(biāo)準(zhǔn)品;對照品,標(biāo)準(zhǔn)品;醫(yī)藥原料;分析對照品;Alkaloids;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;natural product;Inhibitors;標(biāo)準(zhǔn)品-中藥標(biāo)準(zhǔn)品;生物堿;標(biāo)準(zhǔn)品 -中藥標(biāo)準(zhǔn)品;分析試劑-標(biāo)準(zhǔn)品;分析試劑;標(biāo)準(zhǔn)品,對照品;其他原料;化工原料;分析試劑標(biāo)準(zhǔn)品;含量產(chǎn)品 |
| Mol文件 | 2447-54-3.mol |
| 結(jié)構(gòu)式 | ![]() |
血根堿 性質(zhì)
| 熔點 | 205-215°C |
|---|---|
| 沸點 | 483.53°C (rough estimate) |
| 密度 | 1.3463 (rough estimate) |
| 折射率 | 1.5180 (estimate) |
| 儲存條件 | Keep in dark place,Sealed in dry,Room Temperature |
| 溶解度 | 可溶于氯仿(少許)、DMSO(少許) |
| 形態(tài) | 固體 |
| 顏色 | 白色 |
| LogP | -0.653 (est) |

圖1為血根堿化學(xué)結(jié)構(gòu)式
臨床研究結(jié)果表明,血根堿對口腔中大多數(shù)細(xì)菌有抑菌和殺菌作用,并有干擾細(xì)菌粘附于剛形成的牙膜上的作用。含血根堿提取物(SaE)/氯化鋅的牙膏和漱口液的臨床試驗表明,用含質(zhì)量分?jǐn)?shù)為0.075%SaE、質(zhì)量分?jǐn)?shù)為2.0%或更多的氯化鋅牙膏和含質(zhì)量分?jǐn)?shù)為0.03%SaE、質(zhì)量分?jǐn)?shù)為0.2%氯化鋅漱口液進(jìn)行試驗,7位試驗者牙菌斑全部減少,牙齦健康改善,其中3位經(jīng)歷6個月后見效。短期試驗的效果還有待進(jìn)一步證實。
血根堿作用機(jī)理還需要進(jìn)一步探討。氯化鋅和血根堿各自對復(fù)配物活性的貢獻(xiàn)還不清楚,市售含血根堿的牙膏是含有陽離子抗菌劑和陰離子表面活性劑(月桂基硫酸酯鈉鹽) 的配方,在該牙膏中血根堿(陽離子抗菌劑)仍然保持其抗菌活性,其原因還不清楚。
以上信息由Chemicalbook彤彤編輯整理。Sanguinarine (Sanguinarin) 是一種來源于 Sanguinaria Canadensis 的生物堿,可通過激活活性氧 (ROS) 的產(chǎn)生來刺激細(xì)胞凋亡。Sanguinarine 誘導(dǎo)的細(xì)胞凋亡與 JNK 和 NF-κB 的活化有關(guān)。
Apoptosis
Sanguinarine (SANG)-induced apoptosis is associated with the activation of JNK and NF-κB signal pathways.To determine the effects of Sanguinarine on cell viability, 22B-cFluc cells are stimulated with different concentrations of Sanguinarine for 24 h, and then a CKK-8 assay is performed. The treatment with Sanguinarine decreases the proliferation of 22B cells in a dose-dependent manner. Meanwhile, the cytosolic extracts of 22B-cFluc cells treated with different dose of Sanguinarine are measured to detect cellular caspase-3 activity using Ac-DEVD-pNA, which is a validated caspase-3 substrate. The absorbance at 450 nm increases in a dose-dependent manner, indicating increased caspase-3 activity stimulated by Sanguinarine.
To evaluate the apoptosis induced by Sanguinarine (SANG) in vivo, 22B-cFluc cells are inoculated subcutaneously into one flank of nude mice and xenograft models are allowed to establish. Mice are treated intravenously with 10 mg/kg of Sanguinarine. At 24, 48 and 72 h after treatment, bioluminescent imaging is performed after i.p. injection of mice with 150 mg/kg of D-luciferin substrate. Sanguinarine treatment induces an obvious increase of luminescent signal as early as 48 h after initial treatment. A sustained bioluminescent imaging (BLI) intensity increased is observed throughout the course of experiment. At 72 h after treatment, the tumors are collected and subjected to TUNEL staining for evaluating apoptosis. Compared with the control tumors, the group treated with Sanguinarine exhibits significantly more cell apoptosis, indicated by the increased green signals from the sporadic apoptotic cells.
藥理藥效:具有抗菌、殺蟲作用,改善肝功能、增強(qiáng)免疫力,有一定的抗腫瘤作用。
